SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001204459-10-001082
Filing Date
2010-05-13
Accepted
2010-05-13 08:44:43
Documents
28
Period of Report
2010-05-13
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 10626
2 EXHIBIT 99.1 exhibit99-1.htm EX-99.1 4904
3 exhibi1.jpg GRAPHIC 45005
4 exhibi2.jpg GRAPHIC 189336
5 exhibi3.jpg GRAPHIC 127279
6 exhibi4.jpg GRAPHIC 124824
7 exhibi5.jpg GRAPHIC 94086
8 exhibi6.jpg GRAPHIC 94564
9 exhibi7.jpg GRAPHIC 125164
10 exhibi8.jpg GRAPHIC 122622
11 exhibi9.jpg GRAPHIC 71323
12 exhibi10.jpg GRAPHIC 115997
13 exhibi11.jpg GRAPHIC 115916
14 exhibi12.jpg GRAPHIC 63979
15 exhibi13.jpg GRAPHIC 104897
16 exhibi14.jpg GRAPHIC 89098
17 exhibi15.jpg GRAPHIC 95210
18 exhibi16.jpg GRAPHIC 83563
19 exhibi17.jpg GRAPHIC 94272
20 exhibi18.jpg GRAPHIC 67457
21 exhibi19.jpg GRAPHIC 81655
22 exhibi20.jpg GRAPHIC 73678
23 exhibi21.jpg GRAPHIC 66056
24 exhibi22.jpg GRAPHIC 101109
25 exhibi23.jpg GRAPHIC 68509
26 exhibi24.jpg GRAPHIC 84516
27 exhibi25.jpg GRAPHIC 127295
28 exhibi26.jpg GRAPHIC 35416
  Complete submission text file 0001204459-10-001082.txt   3413312
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Filer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34236 | Film No.: 10826589
SIC: 2834 Pharmaceutical Preparations